If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmith & Nephew Regulatory News (SN.)

Share Price Information for Smith & Nephew (SN.)

Share Price is delayed by 15 minutes
Get Live Data
1,126.50    32.00 (2.92%)
Bid:
1,127.00
Ask:
1,128.00
Spread: 1.00 (0.089%)
Market Cap: £9.52b
SN. Live PriceLast checked at - London Stock Exchange

Intraday Smith & Nephew Share Chart

Director/PDMR Shareholding

13 Aug 2025 17:08

RNS Number : 2390V
Smith & Nephew Plc
13 August 2025
 

SMITH & NEPHEW PLC

 

13 August 2025

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM.

 

1. VESTING OF SHARE AWARDS UNDER THE GLOBAL SHARE PLAN 2020

 

On 13 August 2025, the Company received notification of the following transactions in US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") following the vesting of awards under the Smith & Nephew Global Share Plan 2020.

 

All figures in these columns are stated to 6 decimal places where applicable.

 

 

PARTIAL VESTING OF 2023 CONDITIONAL AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2020:

 

The awards were granted under the Global Share Plan 2020 on 11 August 2023. One third of the award vests in equal tranches over the following three years. A number of shares were sold to cover taxation obligations arising on the vesting of the awards.

 

The following relates to individuals included in the below notification:

 

Reason for the notification

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

 

Smith & Nephew plc ordinary shares of USD 0.20 each

 

Identification code

ISIN: GB0009223206

Nature of the transaction

Partial vesting on 12 August 2025 of Conditional Share awards granted on 11 August 2023 under the Smith & Nephew Global Share Plan 2020, and subsequent sale of shares to cover tax liability

Date of Transaction

2025 - 08 - 12

Place of Transaction

London Stock Exchange (XLON)

 

 

Name

(Position)

 

Status

Price (£)

Volume

Aggregated information

Rohit Kashyap

(President, Advanced Wound Management and Global

PDMR

13.571365

23,201 (of which 5,670 were sold and 17,531 were retained.)

N/A Single Transaction

 

 

 

Helen Barraclough

Company Secretary

Smith & Nephew plc

 

Tel: +44 (0)1923 477100

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFIRTEIVLIE
Date   Source Headline
27th Sep 20165:46 pmRNSTransaction in Own Shares
26th Sep 20165:46 pmRNSTransaction in Own Shares
23rd Sep 20165:49 pmRNSTransaction in Own Shares
22nd Sep 20165:35 pmRNSTransaction in Own Shares
21st Sep 20165:38 pmRNSTransaction in Own Shares
20th Sep 20166:01 pmRNSTransaction in Own Shares
19th Sep 20165:58 pmRNSTransaction in Own Shares
16th Sep 20165:46 pmRNSTransaction in Own Shares
16th Sep 201611:56 amRNSAdditional Listing
15th Sep 20165:45 pmRNSTransaction in Own Shares
13th Sep 20165:52 pmRNSDirector/PDMR Shareholding
12th Sep 20165:36 pmRNSTransaction in Own Shares
9th Sep 20165:28 pmRNSTransaction in Own Shares
8th Sep 20165:33 pmRNSTransaction in Own Shares
7th Sep 20165:34 pmRNSTransaction in Own Shares
6th Sep 20165:25 pmRNSTransaction in Own Shares
5th Sep 20165:46 pmRNSTransaction in Own Shares
2nd Sep 20165:48 pmRNSTransaction in Own Shares
1st Sep 20165:52 pmRNSTransaction in Own Shares
1st Sep 20164:47 pmRNSTotal Voting Rights
31st Aug 20165:35 pmRNSTransaction in Own Shares
30th Aug 20165:36 pmRNSTransaction in Own Shares
26th Aug 20165:31 pmRNSTransaction in Own Shares
25th Aug 20165:52 pmRNSTransaction in Own Shares
24th Aug 20165:41 pmRNSTransaction in Own Shares
23rd Aug 20165:31 pmRNSTransaction in Own Shares
22nd Aug 20166:05 pmRNSTransaction in Own Shares
19th Aug 20165:26 pmRNSTransaction in Own Shares
19th Aug 20164:07 pmRNSDirector/PDMR Shareholding
18th Aug 20165:43 pmRNSTransaction in Own Shares
16th Aug 20165:48 pmRNSDirector/PDMR Shareholding
16th Aug 20165:42 pmRNSTransaction in Own Shares
12th Aug 20165:30 pmRNSTransaction in Own Shares
11th Aug 20165:34 pmRNSTransaction in Own Shares
11th Aug 20165:31 pmRNSHolding(s) in Company
10th Aug 20165:32 pmRNSTransaction in Own Shares
9th Aug 20166:26 pmRNSTransaction in Own Shares
9th Aug 201611:45 amRNSDirector Declaration
8th Aug 20166:17 pmRNSTransaction in Own Shares
8th Aug 20167:00 amRNSCompletion of Sale and Commencement of buy-back
3rd Aug 20166:07 pmRNSTransaction in Own Shares
2nd Aug 20166:30 pmRNSBlock listing Interim Review
2nd Aug 20166:27 pmRNSTransaction in Own Shares
1st Aug 20165:25 pmRNSTransaction in Own Shares
1st Aug 20165:24 pmRNSTotal Voting Rights
28th Jul 20167:00 amRNSHalf-year Report
13th Jul 20163:12 pmRNSNotice of Results
11th Jul 20161:56 pmRNSDirectorate Change
6th Jul 20165:44 pmRNSDirector/PDMR Shareholding
1st Jul 20162:55 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.